ASCENDIS PHARMA A/S shareholders Q3 2023

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 164 filers reported holding ASCENDIS PHARMA A/S in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.

ASCENDIS PHARMA A/S shareholders Q3 2023
NameSharesValueWeighting ↓
Walleye Capital LLC 3,100$290,2840.00%
GROUP ONE TRADING, L.P. 2,844$266,3120.00%
CULLEN/FROST BANKERS, INC. 100$9,3640.00%
Parallel Advisors, LLC 38$3,5580.00%
WELLS FARGO & COMPANY/MN 9,935$930,2720.00%
FIFTH THIRD BANCORP 174$16,2930.00%
OSAIC HOLDINGS, INC. 1,162$108,7810.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Legal & General Group Plc 1,038$97,2330.00%
BNP PARIBAS FINANCIAL MARKETS 745$69,7620.00%
CI INVESTMENTS INC. 948$890.00%
STATE STREET CORP 30,727$2,877,2760.00%
RHUMBLINE ADVISERS 1,268$118,7320.00%
PRIVATE TRUST CO NA 33$3,0900.00%
RAYMOND JAMES & ASSOCIATES 3,355$314,1620.00%
BESSEMER GROUP INC 544$510.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 124$11,6110.00%
Walleye Trading LLC 1,500$140,4600.00%
Walleye Trading LLC 2,000$187,2800.00%
ROYAL BANK OF CANADA 6,863$642,0000.00%
External links

This page lists ASCENDIS PHARMA A/S's shareholders in Q3 2023. To view ASCENDIS PHARMA A/S's shareholder history, click here.